SOX17 loss-of-function variation underlying familial congenital heart disease
- PMID: 33794346
- DOI: 10.1016/j.ejmg.2021.104211
SOX17 loss-of-function variation underlying familial congenital heart disease
Abstract
As the most prevalent form of human birth defect, congenital heart disease (CHD) contributes to substantial morbidity, mortality and socioeconomic burden worldwide. Aggregating evidence has convincingly demonstrated that genetic defects exert a pivotal role in the pathogenesis of CHD, and causative mutations in multiple genes have been causally linked to CHD. Nevertheless, CHD is of pronounced genetic heterogeneity, and the genetic components underpinning CHD in the overwhelming majority of patients remain obscure. In this research, a four-generation consanguineous family suffering from CHD transmitted in an autosomal dominant mode was recruited. By whole-exome sequencing and bioinformatics analyses as well as Sanger sequencing analyses of the family members, a new heterozygous SOX17 variation, NM_022454.4: c.553G > T; p.(Glu185*), was identified to co-segregate with CHD in the family, with complete penetrance. The nonsense variation was neither detected in 310 unrelated healthy volunteers used as controls nor retrieved in such population genetics databases as the Exome Aggregation Consortium database, Genome Aggregation Database, and the Single Nucleotide Polymorphism database. Functional assays by utilizing a dual-luciferase reporter assay system unveiled that the Glu185*-mutant SOX17 protein had no transcriptional activity on its two target genes NOTCH1 and GATA4, which have been reported to cause CHD. Furthermore, the mutation abrogated the synergistic transactivation between SOX17 and NKX2.5, another established CHD-causing transcription factor. These findings firstly indicate SOX17 loss-of-function mutation predisposes to familial CHD, which adds novel insight to the molecular mechanism of CHD, implying potential implications for genetic risk appraisal and individualized prophylaxis of the family members affected with CHD.
Keywords: Congenital heart defect; Molecular genetics; Reporter gene assay; SOX17; Transcription factor.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.
Similar articles
-
SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension.Int Heart J. 2021 May 29;62(3):566-574. doi: 10.1536/ihj.20-711. Epub 2021 May 1. Int Heart J. 2021. PMID: 33952808
-
KLF13 loss-of-function variation contributes to familial congenital heart defects.Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11273-11285. doi: 10.26355/eurrev_202011_23617. Eur Rev Med Pharmacol Sci. 2020. PMID: 33215447
-
A novel NR2F2 loss-of-function mutation predisposes to congenital heart defect.Eur J Med Genet. 2018 Apr;61(4):197-203. doi: 10.1016/j.ejmg.2017.12.003. Epub 2017 Dec 6. Eur J Med Genet. 2018. PMID: 29222010
-
An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations.Expert Rev Mol Diagn. 2017 Apr;17(4):393-401. doi: 10.1080/14737159.2017.1300062. Epub 2017 Mar 8. Expert Rev Mol Diagn. 2017. PMID: 28274167 Review.
-
Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature.Genes (Basel). 2023 Oct 20;14(10):1965. doi: 10.3390/genes14101965. Genes (Basel). 2023. PMID: 37895315 Free PMC article. Review.
Cited by
-
Associations of Transcription Factor 21 Gene Polymorphisms with the Growth and Body Composition Traits in Broilers.Animals (Basel). 2022 Feb 8;12(3):393. doi: 10.3390/ani12030393. Animals (Basel). 2022. PMID: 35158719 Free PMC article.
-
A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.Exp Ther Med. 2022 Apr;23(4):311. doi: 10.3892/etm.2022.11240. Epub 2022 Mar 1. Exp Ther Med. 2022. PMID: 35369534 Free PMC article.
-
Somatic GATA4 mutation contributes to tetralogy of Fallot.Exp Ther Med. 2024 Jan 8;27(2):91. doi: 10.3892/etm.2024.12379. eCollection 2024 Feb. Exp Ther Med. 2024. PMID: 38274337 Free PMC article.
-
SMAD1 Loss-of-Function Variant Responsible for Congenital Heart Disease.Biomed Res Int. 2022 Mar 3;2022:9916325. doi: 10.1155/2022/9916325. eCollection 2022. Biomed Res Int. 2022. PMID: 35281600 Free PMC article.
-
Discovery of GJC1 (Cx45) as a New Gene Underlying Congenital Heart Disease and Arrhythmias.Biology (Basel). 2023 Feb 21;12(3):346. doi: 10.3390/biology12030346. Biology (Basel). 2023. PMID: 36979038 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials